CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) will present new clinical data supporting the company’s marketed and investigational therapies for neurological diseases at the 67th American Academy of Neurology (AAN) Annual Meeting in Washington D.C., April 18 – 25, 2015. The 73 company-sponsored platform and poster presentations represent Biogen’s enduring commitment to develop innovative medicines that have the potential to transform patient lives and create solutions that enhance understanding of neurodegenerative diseases and management.
Help employers find you! Check out all the jobs and post your resume.
